2,004
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Influences of patient education on exacerbations and hospital admissions in patients with COPD – a longitudinal national register study

, &
Article: 1500073 | Received 10 Jan 2018, Accepted 05 Jul 2018, Published online: 31 Jul 2018

References

  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology. 2017;22(3):575–13.
  • Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. JRSM. 2007;100(5):225–233.
  • Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
  • Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191.
  • Ståhl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3:56.
  • Henoch I, Strang S, Löfdahl CG, et al. Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics. Eur Clin Respir J. 2016;3(1):31459.
  • Sundh J, Ekström M. Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:2805–2812.
  • Sundh J, Montgomery S, Hasselgren M, et al. Change in health status in COPD: a seven-year follow-up cohort study. NPJ Prim Care Respir Med. 2016;26:16073.
  • Soler-Cataluna JJ, Martinez-Garcia MA, Sanchez LS, et al. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 2009;103(5):692–699.
  • Dickens C, Katon W, Blakemore A, et al. Complex interventions that reduce urgent care use in COPD: a systematic review with meta-regression. Respir Med. 2014;108(3):426–437.
  • Howcroft M, Walters EH, Wood-Baker R, et al. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005074.
  • Peytremann-Bridevaux I, Staeger P, Bridevaux PO, et al. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med. 2008;121(5):433–43.e4.
  • Worth H, Dhein Y. Does patient education modify behaviour in the management of COPD? Patient Educ Couns. 2004;52(3):267–270.
  • Kanner RE, Anthonisen NR, Connett JE. Lung Health Study Research Group. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164(3):358–364).
  • Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188–207.
  • Borglykke A, Pisinger C, Jorgensen T, et al. The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD). Clin Respir J. 2008;2(3):158–165.
  • Van Eerd EA, Van Der Meer RM, Van Schayck OC, et al. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;8:CD010744.
  • National Board of Health and Welfare. National guidelines for care of asthma and COPD. Support for management and administration. [Swedish: nationella riktlinjer för vård vid astma och KOL. Stöd för styrning och ledning] [Internet] 2015. [cited 2017 Oct 24]. Available from: http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19949/2015-11-3.pdf
  • Van Der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1:13.
  • Zhou Z, Zhou A, Zhao Y, et al. Evaluating the clinical COPD questionnaire: a systematic review. Respirology. 2017;22(2):251–262.
  • Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
  • Strang S, Ekberg-Jansson A, Henoch I. Experience of anxiety among patients with severe COPD: a qualitative, in-depth interview study. Palliat Support Care. 2013;12(6):1–8.
  • Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient’s perspective using discrete choice modelling. Eur Respir J. 2005;26(4):623–629.
  • Kessler R, Ståhl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest. 2006;130(1):133–142.
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138.
  • Zhang J, Lin X-F, Bai C-X. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2014;9:57–63.
  • Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;10:CD009437.
  • Barnes N, Calverley PM, Kaplan A, et al. Chronic obstructive pulmonary disease and exacerbations: patient insights from the global hidden depths of COPD survey. BMC Pulm Med. 2013;13(1):54.
  • Jonsdottir R, Jonsdottir H. The experience of women with advanced chronic obstructive pulmonary disease of repeatedly relapsing to smoking. Scand J Caring Sci. 2007;21(3):297–304.